These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 34363280
1. Two-year outcomes from the MitrAl ValvE RepaIr Clinical (MAVERIC) trial: a novel percutaneous treatment of functional mitral regurgitation. Patterson T, Gregson J, Erglis A, Joseph J, Rajani R, Wilson K, Prendergast B, Worthley S, Hildick-Smith D, Rafter T, Whelan A, De Marco F, Horrigan M, Redwood SR. Eur J Heart Fail; 2021 Oct; 23(10):1775-1783. PubMed ID: 34363280 [Abstract] [Full Text] [Related]
12. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation. Ailawadi G, Lim DS, Mack MJ, Trento A, Kar S, Grayburn PA, Glower DD, Wang A, Foster E, Qasim A, Weissman NJ, Ellis J, Crosson L, Fan F, Kron IL, Pearson PJ, Feldman T, EVEREST II Investigators. Circulation; 2019 Jan 02; 139(1):37-47. PubMed ID: 30586701 [Abstract] [Full Text] [Related]
13. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation. Muller DWM, Sorajja P, Duncan A, Bethea B, Dahle G, Grayburn P, Babaliaros V, Guerrero M, Thourani VH, Bedogni F, Denti P, Dumonteil N, Modine T, Jansz P, Chuang ML, Blanke P, Leipsic J, Badhwar V. J Am Coll Cardiol; 2021 Nov 09; 78(19):1847-1859. PubMed ID: 34736561 [Abstract] [Full Text] [Related]
19. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, Kapadia SR, McCarthy PM, Lim DS, Udelson JE, Zile MR, Gammie JS, Gillinov AM, Glower DD, Heimansohn DA, Suri RM, Ellis JT, Shu Y, Kar S, Weissman NJ, Stone GW. Am Heart J; 2018 Nov 09; 205():1-11. PubMed ID: 30134187 [Abstract] [Full Text] [Related]